Upcoming and Past Presentations

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Treatment of Early-Stage NMSC

In this Project ECHO, we discuss Treatment of Early-Stage Non-Melanoma Skin Cancer

May 6, 2026

Implications for Dermatology

The Evolving Treatment Landscape of Cutaneous Squamous Cell Carcinoma

At the University of Louisville Division of Fine Memorial Lecture, Dr. Miller provides an overview of the evolving treatment landscape of CSCC and its implications for dermatologists

Apr 21, 2026

A Bayesian Causall Analysis of Dose Intensity, Early Benefit and Treatment De-escalation

Frontline Immunotherapy With Response-guided Subsequent Treatment

In this session, Dr. Miller reviews the evolving role of frontline immunotherapy with response-guided subsequent treatment in advanced CSCC. The talk focuses on how early treatment response can inform downstream therapeutic decisions, with an emphasis on optimizing outcomes while minimizing unnecessary toxicity.

Apr 21, 2026

And What We Can Do About It

The Hidden Problem in Dermatology Research

At the University of Louisville Division of Dermatology CME event, Dr. Miller presents an overview of how large analytic search spaces can introduce bias and distort inference in clinical research, with a focus on common pitfalls in dermatology studies.

Apr 20, 2026

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Resistance, Sequencing, and Optimal Treatment Duration

In this Project ECHO, we discuss Resistance, Sequencing, and Optimal Treatment Duration for high-risk Non-Melanoma Skin Cancer

Apr 8, 2026

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Multidisciplinary Team Approach to Care

In this Project ECHO, we discuss multi-disciplinary strategies to manage high-risk Non-Melanoma Skin Cancer

Mar 4, 2026

Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors

Winter Clinical Miami

Feb 28, 2026

Response Assessments for Intra-Tumoral and Other Locoregional Therapies

Feb 12, 2026

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Management of Adverse Events Across Specialties

In this Project ECHO, we discuss multi-disciplinary strategies to management immune-related adverse events from cancer immunotherapy

Feb 11, 2026

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Treatment of Merkel Cell Carcinoma

In this Project ECHO, we summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for Merkel cell carcinoma

Jan 14, 2026

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Treatment of Squamous Cell Carcinoma

In this Project ECHO, we summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for squamous cell carcinoma

Dec 3, 2025

Advancing Care in Keratinocyte Carcinoma

We provide an overview of the evolving clinical evidence on the efficacy and safety of new and upcoming therapeutic strategies for keratinocyte carcinoma, with practical guidance tailored to the needs and responsibilities of APPs

Nov 19, 2025

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Treatment of Basal Cell Carcinoma

In this Project ECHO, we summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for basal cell carcinoma

Nov 5, 2025

David M. Miller, Kevin S. Emerick

Evolving Standards in Keratinocyte Carcinoma

We summarize the clinical evidence on the efficacy and safety of new and emerging therapies for keratinocyte carcinoma and highlight the central role of multidisciplinary care.

Oct 28, 2025

Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for keratinocyte carcinoma

Oct 25, 2025

Axel Hauschild, David M. Miller, Vishal A. Patel, Marlies Wakkee

Building Consensus in Nonmelanoma Skin Cancer Care. Applying Emerging Science and Best Practices

Management Pearls for Advanced NMSC

Oct 20, 2025

The Keratinoctye Carcinoma Talk Show

This live program will explore key clinical practice insights for patients with keratinoctye carcinoma.

David M. Miller, Vishal A. Patel, Kevin S. Emerick, Anokhi Jambusaria

Current Controversies in Cutaneous Oncology

This live program will explore current controversies in melanoma and keratinocyte carcinoma.

David M. Miller, Vishal A. Patel, Mehran Yusuf, Kevin S. Emerick, Laura K. Ferris, Vernon K. Sondak

Expert Dialogues in Melanoma and Cutaneous T-Cell Lymphoma

This live program will explore key clinical practice insights for patients with melanoma and cutaneous T-cell lymphoma.

David M. Miller, Steven Chen, Laura K. Ferris, Vernon K. Sondak

Multidisciplinary Management of Nonmelanoma Skin Cancer

This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer.

David M. Miller, Kevin S. Emerick, Vishal A. Patel, Sonia Cohen, Sunandana Chandra

Cutaneous Oncology Tumor Board

This live program will discuss complex cases in melanoma and keratinocyte carcinoma.

David M. Miller, Vishal A. Patel, Mehran Yusuf, Kevin S. Emerick, Vernon K. Sondak

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

May 30, 2025

David M. Miller, Vishal A. Patel

A Tailored Approach to Non-Melanoma Skin Cancers: Managing the High-Risk Patient With Systemic Immune-Activating Therapy

At the 2025 ACMS meeting Drs. Miller and Patel discuss pearls in managing the high-risk patient with systemic immune-activating therapy

May 16, 2025

The Evolving Treatment Landscape of Non-Melanoma Skin Cancer: Implications for Dermatology

At the GW School of Medicine Dermatology Grand Rounds, Dr. Miller provides an overview of the evolving treatment landscape of CSCC and its implications for dermatologists

May 15, 2025

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At a GW Dermatology resident lecutre in Washington D.C., Dr. Miller provides an overview of the current concepts in diagnosis and management of Merkel Cell Carcinoma

May 15, 2025

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in diagnosis and management of Merkel Cell Carcinoma

May 2, 2025

Peri-Operative Management of CSCC

May 2, 2025

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on the recently published CheckMate-358

Apr 10, 2025

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Mar 19, 2025

Peri-operative Management of High-Risk CSCC

At the 2025, American Academy of Dermatology Annual Meeting ‘What’s New in the Management of Advanced Skin Cancer’ session, Dr. Miller provides pearls on the peri-operative management of high-risk CSCC

Mar 9, 2025

David M. Miller, Vishal Patel

Narrowing Nonmelanoma Skin Cancer Gaps With Neoadjuvant Immunotherapy: Multidisciplinary Strategies for Success

At a AiCME program held at the 2025 American Academy of Dermatology Annual Meeting, Drs. Miller and Patel explore key clinical practice insights for patients with high-risk resectable NMSC

Mar 9, 2025

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on ctDNA in MCC

Mar 3, 2025

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Feb 3, 2025

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

Controversies in Gene Expression Profiling

Jan 19, 2025

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

Immunotherapy for CSCC - What Dermatologists Should Know

Jan 19, 2025

Collaborative Approaches to Optimize Basal Cell Carcinoma Care Within the Community

Management Pearls for Advanced BCC

Jan 8, 2025

The Evolving Treatment Landscape for CSCC

Reflections on the evolving treatment landscape for CSCC

Oct 24, 2024

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Oct 1, 2024

Optimizing Melanoma Outcomes in Rural and Underserved Communities: Adapting to Evolving Treatment Paradigms

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous melanoma

Sep 28, 2024

Update in the Management of Advanced Cutaneous Squamous Cell Carcinoma

This live program will explore key clinical practice insights for patients with advanced CSCC

Sep 21, 2024

Update in the Management of Non-Resectable Melanoma

This live program will explore key clinical practice insights for patients with non-resectable melanoma

Sep 21, 2024

Shifting the Approach to Nonmelanoma Skin Cancer in Dermatology

This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Sep 20, 2024

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Sep 19, 2024

David M. Miller, Todd Schlessinger

A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies

This program will explore key clinical practice insights for patients with advanced basal cell carcinoma

Sep 4, 2024

Incorporating Multidisciplinary Care and Immunotherapy to Achieve Optimal Outcomes in Patients With Nonmelanoma Skin Cancers

This HoloVision program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Aug 9, 2024

Should Ipilimumab Be the New “Standard” for Refractory MCC?

We discuss the role of Ipilimumab in anti-PD1 refractory MCC

May 3, 2024

Updates in Merkel Cell Carcinoma

Pearls on the current concepts in diagnosis and management of MCC

Mar 10, 2024

Peri-operative Management of CSCC

Pearls on peri-omanagement of high-risk resectable CSCC

Mar 9, 2024

The Prognostic Value of the MCPyV Serum Antibody Test

We discuss results from a dual-institution observational study

Mar 8, 2024

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Jan 19, 2024

ODAC Dermatology, Aesthetic & Surgical Conference “Medical & Surgical Dermatology Topics”

Melanoma Update

Jan 14, 2024

ODAC Dermatology, Aesthetic & Surgical Conference “Non-Melanoma Skin Cancer Update”

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

Jan 13, 2024

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Jan 5, 2024

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Jan 3, 2024

Vishal A. Patel, David M. Miller, Theresa Guo

Interdisciplinary Management of Advanced Cutaneous Malignancy

Management Pearls for the Peri-Operative Management of Melanoma

Nov 3, 2023

Putting the Patient First. The Value of Personalized Medicine for Nonmelanoma Skin Cancers

Management Pearls for Advanced NMSC

Oct 22, 2023

Management of Cutaneous Melanoma

Oct 11, 2023

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Current concepts in diagnosis and management of MCC

Sep 22, 2023

Nicotinamide For Skin Cancer After Transplant

Discuss the evidende behind the use of nicotinamide for skin cancer prevention

Sep 14, 2023

Prognostic Significance of Initial AMERK Serostatus

We discuss results from a dual-institution observational study

Aug 18, 2023

Immunotherapeutic Strategies in Skin Cancer

Primer on Immunotherapeutic Strategies in Skin Cancer

Aug 2, 2023

StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries

We present an overview of the StoryboardR package

Jun 8, 2023

The Emerging Standard of Care - Immunotherapy in Non-Melanoma Skin Cancer

This live program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Jun 5, 2023

Mission - Impossible to Possible Using Immunotherapy for the Treatment of Nonmelanoma Skin Cancers

Management Pearls for Advanced CSCC

Jun 4, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

May 25, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

May 22, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

May 10, 2023

David M. Miller, Sailesh Konda

Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer

This live hybrid program will explore key clinical practice insights for patients with advanced and high-risk resectable NMSC

May 6, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

May 1, 2023

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

Apr 21, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Apr 12, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Apr 10, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Apr 6, 2023

Integrating the Latest Evidence on Management of Basal Cell Carcinoma

We discuss implementation of evidence-based strategies for reducing disparities in basal cell carcinoma (BCC) care in rural and underserved settings

Apr 1, 2023

Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous squamous cell carcinoma

Apr 1, 2023

ICARUS

We discuss a trial concept for high-risk CSCC

Mar 31, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Mar 30, 2023

David M. Miller, Vishal A. Patel

Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma

This live program will explore key clinical practice insights for patients with advanced cutaneous squamous cell carcinoma

Mar 19, 2023

Updates in Merkel Cell Carcinoma

Pearls on the current concepts in diagnosis and management of MCC

Mar 18, 2023

Management of High Risk Uncommon Cutaneous Neoplasms

Pearls on the current concepts in diagnosis and management of uncommon cutaneous neoplasms

Mar 17, 2023

Management of Operable Advanced NMSC

Pearls on the current concepts in diagnosis and management of operable non-melanoma skin cancer

Mar 17, 2023

How do we implement systemic therapy to reduce recurrence of high-risk melanomas: from neoadjuvant to adjuvant therapy?

Pearls on the current concepts in peri-operative management of high-risk melanoma

Mar 17, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Mar 13, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Mar 9, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Mar 2, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Feb 23, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Feb 15, 2023

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Feb 15, 2023

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

Feb 13, 2023

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Feb 8, 2023

Med Learning Group TeleECHO. Event URL

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Feb 6, 2023

David M. Miller, Vishal A. Patel

New Systemic Therapies for the Treatment of Advanced Non-Melanoma Skin Cancers: Which of Your Patients May Benefit?

We review new systemic therapies for the Treatment of Advanced NMSCs

Jan 23, 2023

The Essential Roles of Dermatologists in Managing Patients with Advanced Basal Cell Carcinoma

This gamification-based activity highlights how to diagnose, treat, and/or manage patients with advanced basal cell carcinoma.

Nov 22, 2022

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Nov 21, 2022

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Nov 18, 2022

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Nov 17, 2022

Med Learning Group TeleECHO. Event URL

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Nov 9, 2022

David M. Miller, Douglas Grossman, Steven Wang, Vishal A. Patel

Cutaneous Malignancies: How Would You Manage This Patient?

Interactive session with a series of skin cancer experts discussing management of complex skin cancer patients.

Nov 4, 2022

Prognostic Gene Expression Profiling for Cutaneous Squamous Cell Carcinoma: Does it Add to Staging

We discuss the current data regarding prognostic gene expression profiling in CSCC

Nov 4, 2022

David M. Miller, Kavita Sarin, Vishal A. Patel

Cases in Basal Cell Carcinoma: Fostering Interdisciplinary Care

We discuss cases in the management of advanced BCC.

Nov 4, 2022

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Med Learning Group TeleECHO. Event URL

Oct 26, 2022

Isaac Brownell, David M. Miller, Sunandana Chandra, Emily S. Ruiz

Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer

We discuss perals from the recent SITC practice guidelines on NMSC

Oct 3, 2022

Immunotherapeutic Strategies in Skin Cancer

Primer on Immunotherapeutic Strategies in Skin Cancer

Aug 17, 2022

The Clinician Investigator - A Buttress Against Type III Error or a Contributor to the Crisis in Reproducibility?

In this two part series, we discuss elements of the crisis in reproducibility in clinical research.

Jul 11, 2022

Dealing with Non-Responders to Systemic Therapy for Basal Cell Carcinoma

In this podcase, we discuss pearls on the management of advanced BCC

Jun 13, 2022

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

May 6, 2022

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

Pearls in the management of Merkel Cell Carcinoma

Apr 30, 2022

Basal Cell Carcinoma: How to Effectively Manage Your Patients

Pearls in the management of Basal Cell Carcinoma

Apr 30, 2022

Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma

Real world evaluation of initial brain MRI in MCC

Apr 26, 2022

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Apr 25, 2022

Axel Hauschild, David M. Miller, Vishal Patel

Seeing Nonmelanoma Skin Cancers Through a New Lens - The Role and Place of Immunotherapy

Pearls on the current concepts in diagnosis and management of NMSC

Apr 22, 2022

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Pearls on the current concepts in diagnosis and management of MCC

Mar 28, 2022

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Mar 25, 2022

Kevin Emerick, David M. Miller

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Mar 25, 2022

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Mar 18, 2022

Kevin Emerick, David M. Miller

Management of Advanced Cutaneous Melanoma

Pearls for the work up and management of cutaneous melanoma

Mar 10, 2022

Vishal Patel, Krista Rubin, David M. Miller

Non Melanoma Skin Cancer Immunotherapies and the Role of Dermatology Clinicians

Management Pearls for Advanced NMSC

Mar 1, 2022

Immunotherapy in Advanced NMSC - Treatment Selection and Collaborative Care

Pearls for the Management of Advanced NMSC

Feb 14, 2022

Vishal Patel, Krista Rubin, David M. Miller

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

Jan 14, 2022

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

Jan 7, 2022

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

This live virtual Grand Rounds program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

Dec 14, 2021

Clinical and Translational Research in Cutaneous Oncology

Pearls for a career in CT research in skin cancer

Dec 3, 2021

Management of Cutaneous Melanoma

In this lecture to the Harvard Dermatology residents, we provide pearls for the management of cutaneous melanoma

Dec 3, 2021

David M. Miller, Kerry Reynolds, Bill Louv

Accelerate Health

At the 2021 CEO Roundtable on Cancer Annual Conference we provide an update on the PDS MCC patient registry

Nov 17, 2021

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

Nov 11, 2021

The MCC Patient Registry - From Promise to Prototype to Patient

For this MGH Dermatology Grand Rounds we present an overview of the PDS MCC patient registry

Nov 2, 2021

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

Oct 8, 2021

Squamous Cell Carcinoma - Current Concepts in Management

In this lecture for the Nurse Practioners on the Medical Oncology Inpatient Service, we reivew pearls on the current concepts in management of SCC

Oct 4, 2021

David M. Miller, Sophia-Shalhout

GENETEX - A GENomics Report TEXt Mining R Package to Capture Real-World Clinico-genomic Data

We present an overview of the GENETEX package

Aug 26, 2021

Nonmelanoma Skin Cancers - Who Is in the Waiting Room

Pearls on the current concepts in diagnosis and management of NMSC

Aug 7, 2021

David M. Miller, Hari Nadiminti, Vishal Patel

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

In this talk for the Summer AAD we review pearls on the current concepts in diagnosis and management of MCC.

Aug 7, 2021

Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma

We discuss the utility of brain MRI for the initial staging of MCC

Jul 19, 2021

Farees Saqlain

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Pearls on the current concepts in diagnosis and management of MCC

Jun 11, 2021

eLAB - a Large-Scale Laboratory Integration Informatics Pipeline for Clinical Research

May 17, 2021

GENETEX - an NLP R Package for Text Mining Genomic Reports

May 7, 2021

Kevin Emerick, Gina Jefferson, Miriam Lango, Matthew Witek, David M. Miller

Immune Checkpoint Inhibitor for Cutaneous Squamous Cell Carcinoma

Pearls for the Management of Advanced CSCC

Apr 22, 2021

An Innovative View of Advanced and Metastatic Basal Cell Carcinoma- Pathology, Epidemiology, and Treatment Option

Pearls for the Management of Advanced BCC

Mar 22, 2021

David M. Miller, Emily Ruiz

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

Mar 18, 2021

MCC Patient Registry - Lessons Learned, Future Directions

Mar 11, 2021

MCC Patient Registry - Lessons Learned on Data Capture

Feb 26, 2021

Work Up and Management of Cutaneous Melanoma

In this online lecture for the DC Resident Consortium, we provide pearls for the work up and management of cutaneous melanoma

Feb 25, 2021

Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient

We provide updates and future directions of the PDS-GOBDA MCC Registry

Feb 23, 2021

David M. Miller, Emily Ruiz

Developing Immunotherapy for Advanced Disease - Leveraging the Tumorigenesis of Basal Cell Skin Cancer – A Whiteboard View

Pearls for the Management of Advanced BCC

Jan 27, 2021

Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient

We provide updates and future directions of the PDS MCC Registry

Jan 22, 2021

Squamous Cell Carcinoma - Work Up and Management

Pearls for the Work Up & Management of CSCC

Sep 9, 2020

The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology

Analysis of the changing regulatory environment in skin cancer

Sep 9, 2020

Management of Cutaneous Melanoma

Pearls for the management of cutaneous melanoma

Aug 21, 2020

The MCC Patient Registry - Updates and Future Directions

David Miller
Isaac Brownell
Ting Yu
Hazel Moran
Ravikumar Komandur
Bill Louv
Teilo Schaller
Johnathan Rine

Aug 7, 2020

Pearls for the Evaluation of Hyponatremia

Salt, Water, Urine, EAV

Practical pearls to help evaluate hyponatremia

May 24, 2020

The Strong Ion Approach to Acid-Base Disorders

Acid-Base Pearls Part 1

Pearls on how to approach Acid-Base issues commonly seen on inpatient medicine

May 23, 2020

Overview & Learning Objectives

Pearls from the Cascade

May 22, 2020

Overview & Learning Objectives

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Apr 16, 2020

Overview & Learning Objectives

Squamous Cell Carcinoma - Epidemiology, Pathophysiology, Work Up and Management

Feb 28, 2020

Heme-Derm - Principles at the Intersection of Blood and Skin

We review overlapping principles of Dermatology and Hematology

Feb 28, 2020

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

We review current concepts in diagnosis and management for MCC

Feb 8, 2020

The MCC Patient Registry - From Promise to Prototype to Patient

Jan 31, 2020

MCC Patient Registry - Updates and Future Directions

Jan 29, 2020

Skin Toxicities of Anti-Neoplastic Medications

Jan 27, 2020

Melanoma - Pathogenesis, Clinical Features, Work Up & Management

We review key pearls in melanoma pathogenesis and management

Jan 23, 2020

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

Therapeutic Updates in Melanoma - IO for Earlier Stage Disease

Jan 18, 2020

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

Jan 17, 2020

The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology

Dec 13, 2019

Melanoma - Pathogenesis, Clinical Features, Diagnosis and Management

Dec 13, 2019

Targeting the Hippo-YAP Pathway As a novel Therapeutic Approach in Cancer

Dec 12, 2019

A Case of Bimodality Therapy for Merkel Cell Carcinoma

Dec 3, 2019

Farees Saqlain

Clinical Investigation in cSCC - Updates from ASCO and ESMO

Nov 19, 2019

Project Data Sphere and Ongoing Multi-Institutional Database Efforts

We present on the PDS MCC patient registry at the First International Symposium on Merkel Cell Carcinoma

Oct 21, 2019

(https://www.themillerlab.io/talk/harvard_derm_resident_mgods-01-31-17/)↩︎

mGODS - Monoclonal Gammopathies of Dermatological Signficance

Jan 17, 2019

PAMPs DAMPs and Dermatology - Innate Immunity for the Dermatologist

May 8, 2018

mGODS - Monoclonal Gammopathies Of Dermatological Significance

First described↩︎

Dec 19, 2017

In this lecture we review the most common dermatoses that result from monoclonal gammopathies. The lecture also introduces the term mGODS: Monoclonal Gammopathies of…

Jan 31, 2017